While PSA was initially considered a secondary endpoint, its fluctuations are heavily influenced by androgen deprivation therapy (ADT), making it difficult to distinguish whether changes are due to probiotic–prebiotic supplementation, tumor regression, or prostatitis. The gene discussed is KLK3; the disease is urogenital neoplasm.